Bladder Cancer

REVIEW UroToday

Prehabilitation in patients undergoing bladder cancer surgery - A systematic review and meta-analysis. November 1, 2024

Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer. November 1, 2024

Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancer. October 31, 2024

HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance. October 31, 2024

The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution October 30, 2024

Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum-containing chemotherapy: Post hoc analysis of KEYNOTE-052 and LEAP-011. October 30, 2024

Sex Disparity in Non-muscle-invasive Bladder Cancer: Pitfalls of Large Population-based Data Sets and Lessons from an Integrated Analysis. October 30, 2024

Sensitive Detection of Urothelial Cancer via High-volume Urine DNA Analysis. October 30, 2024

Altered immunophenotypic expression in the peripheral bladder cancer immune landscape. October 30, 2024

Long-term recurrence risk, metastatic potential and length of cystoscopic surveillance of low-grade non-muscle invasive bladder cancer. October 30, 2024

Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer. October 29, 2024

Long-term oncologic outcomes and complications of robot-assisted radical cystectomy for the treatment of urothelial carcinoma of the bladder. October 29, 2024

Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION). October 28, 2024

Trends in the use of immediate postoperative intravesical chemotherapy following transurethral resection of bladder tumors. October 28, 2024

Artificial intelligence-based assessment of pre-operative body composition is associated with early complications after radical cystectomy. October 25, 2024

Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274. October 25, 2024

Comparing direct medical care costs of patients with bladder cancer who received an ileal conduit vs. neobladder in the year following cystectomy. October 24, 2024

VI-RADS-Based Algorithm for Bladder Cancer Management Randomized Retrospective Study. October 24, 2024

Muscle-Invasive Bladder Cancer in Non-Curative Patients: A Study on Survival and Palliative Care Needs. October 23, 2024

Comparative effectiveness of robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy for bladder cancer. October 23, 2024

Page 1 of 517